Your browser doesn't support javascript.
loading
Association of High Serum Interleukin-6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis.
Boyapati, Anita; Schwartzman, Sergio; Msihid, Jérôme; Choy, Ernest; Genovese, Mark C; Burmester, Gerd R; Lam, Gordon; Kimura, Toshio; Sadeh, Jonathan; Weinreich, David M; Yancopoulos, George D; Graham, Neil M H.
Afiliación
  • Boyapati A; Regeneron Pharmaceuticals, Tarrytown, New York.
  • Schwartzman S; Hospital for Special Surgery, New York, New York.
  • Msihid J; Sanofi, Chilly-Mazarin, France.
  • Choy E; Cardiff University School of Medicine, Cardiff, UK.
  • Genovese MC; Stanford University Medical Center, Palo Alto, California.
  • Burmester GR; Charité University Medicine, Berlin, Germany.
  • Lam G; Atrium Health, Charlotte, North Carolina.
  • Kimura T; Regeneron Pharmaceuticals, Tarrytown, New York.
  • Sadeh J; Sanofi, Bridgewater, New Jersey.
  • Weinreich DM; Regeneron Pharmaceuticals, Tarrytown, New York.
  • Yancopoulos GD; Regeneron Pharmaceuticals, Tarrytown, New York.
  • Graham NMH; Regeneron Pharmaceuticals, Tarrytown, New York.
Arthritis Rheumatol ; 72(9): 1456-1466, 2020 09.
Article en En | MEDLINE | ID: mdl-32343882

Texto completo: 1 Colección: 01-internacional Asunto principal: Artritis Reumatoide / Metotrexato / Interleucina-6 / Antirreumáticos / Anticuerpos Monoclonales Humanizados / Adalimumab Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Artritis Reumatoide / Metotrexato / Interleucina-6 / Antirreumáticos / Anticuerpos Monoclonales Humanizados / Adalimumab Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2020 Tipo del documento: Article